Evidence map›Paper›PMID 40246836›Full record

ArticleNature communications2025

Hypoxia-induced Wnt5a-secreting fibroblasts promote colon cancer progression.

Akikazu Harada, Yoshiaki Yasumizu, Takeshi Harada, Katsumi Fumoto, Akira Sato, Natsumi Maehara, Ryota Sada, Shinji Matsumoto, Takashi Nishina, Kiyoshi Takeda and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. IntegratingFrontiers in immunology · 2026
    Review
  15. Article
  16. Article
  17. Decreased scleral Wnt5aNature communications · 2025
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Akikazu HaradaCenter for Infectious Disease Education and Research (CiDER), The University of Osaka, Suita, Osaka, Japan. aharada@cider.osaka-u.ac.jp.ORCID http://orcid.org/0000-0002-8123-652X
Yoshiaki YasumizuInstitute for Open and Transdisciplinary Research Initiatives (OTRI), The University of Osaka, Suita, Osaka, Japan.
Takeshi HaradaDepartment of Molecular Biology and Biochemistry, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.
Katsumi FumotoDepartment of Molecular Biology and Biochemistry, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.
Akira SatoDepartment of Molecular Biology and Biochemistry, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.
Natsumi MaeharaDepartment of Molecular Biology and Biochemistry, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.
Ryota SadaCenter for Infectious Disease Education and Research (CiDER), The University of Osaka, Suita, Osaka, Japan.ORCID http://orcid.org/0000-0003-3403-0542
Shinji MatsumotoInstitute for Open and Transdisciplinary Research Initiatives (OTRI), The University of Osaka, Suita, Osaka, Japan.ORCID http://orcid.org/0000-0003-1804-264X
Takashi NishinaDepartment of Biochemistry, Faculty of Medicine, Toho University, Ota-ku, Tokyo, Japan.ORCID http://orcid.org/0000-0003-2301-9874
Kiyoshi TakedaCenter for Infectious Disease Education and Research (CiDER), The University of Osaka, Suita, Osaka, Japan.
Eiichi MoriiDepartment of Pathology, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.
Hisako KayamaLaboratory of Mucosal Immunology, WPI Frontier Immunology Research Center, The University of Osaka, Suita, Osaka, Japan.ORCID http://orcid.org/0000-0001-5676-8228
Akira KikuchiCenter for Infectious Disease Education and Research (CiDER), The University of Osaka, Suita, Osaka, Japan. akikuchi@cider.osaka-u.ac.jp.

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) 21K19407MEXT | Japan Society for the Promotion of Science (JSPS) 22K06932MEXT | Japan Society for the Promotion of Science (JSPS) 22K20791MEXT | Japan Society for the Promotion of Science (JSPS) 23K14566MEXT | Japan Society for the Promotion of Science (JSPS) 23K18241
6 · The paper itself

Abstract

Wnt5a, a representative Wnt ligand that activates the β-catenin-independent pathway, has been shown to promote tumorigenesis. However, it is unclear where Wnt5a is produced and how it affects colon cancer aggressiveness. In this study, we demonstrate that Wnt5a is expressed in fibroblasts near the luminal side of the tumor, and its depletion suppresses mouse colon cancer formation. To characterize the specific fibroblast subtype, a meta-analysis of human and mouse colon fibroblast single-cell RNA-seq data is performed. The results show that Wnt5a is expressed in hypoxia-induced inflammatory fibroblast (InfFib), accompanied by the activation of HIF2. Moreover, Wnt5a maintains InfFib through the suppression of angiogenesis mediated by soluble VEGF receptor1 (Flt1) secretion from endothelial cells, thereby inducing further hypoxia. InfFib also produces epiregulin, which promotes colon cancer growth. Here, we show that Wnt5a acts on endothelial cells, inducing a hypoxic environment that maintains InfFib, thereby contributing to colon cancer progression through InfFib.

Indexed as

Colonic NeoplasmsFibroblastsHypoxiaWnt-5a ProteinAnimalsCell HypoxiaCell Line, TumorDisease ProgressionEndothelial CellsEpiregulinGene Expression Regulation, NeoplasticHumansMiceMice, Inbred C57BLNeovascularization, PathologicEpiregulinWnt-5a ProteinWNT5A protein, humanWnt5a protein, mouse

Identifiers

PMID40246836
PMCPMC12006413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.